Abstract
THE T-cell receptor (TCR) repertoire is selected in the thymus after rearrangement of genes encoding TCR α and β chains1. Selection is based on the recognition by newly emergent T cells of self-ligands associated with molecules of the major histo-compatibility complex: some combinations result in positive selection, others in negative selection. Negative selection, or clonal deletion, is an important mechanism for eliminating autoreactive T cells. A group of self-ligands involved in clonal deletion was identified because they, like exogenous superantigens2, were recognized by almost all T cells expressing particular TCR Vβ genes. Vβ17a T cells are deleted by a tissue-specific ligand3,4; Vβ6, V07, Vβ8.1 and Vβ9 T cells are deleted by the minor lymphocyte-stimulating (Mls) determinant Mls-la (refs 5–8); Vβ3 T cells by Mls-2a and Mls-3a (refs 9,10); Vβ11 T cells11 by ligands encoded by independently segregating genes; and Vβ5 T cells by ligands encoded by two genes12. Chromosome mapping using recombinant inbred strains of mice and classic backcrosses show that Mls-la in DBA/2 mice is encoded on chromosome 1, that one of the two ligand genes for deletion of Vβ5 T cells maps to chromosome 12 (ref. 12) and that a ligand gene for Vβ11 deletion is linked to the CDS locus on chromosome 6 (ref. 11). Here we present evidence from three sets of backcross mice for concordance between Vβ11 deletion ligand genes on chromosomes 6,12 and 14 and endogenous mouse mammary tumour virus integrant (Mtv) genomes. Our results indicate that the Vβ11 deletion ligands are products of Mtv genomes.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Lawlor, D. A., Zemmour, J., Ennis, P. D. & Parham, P. A. Rev. Immun. 8, 23–63 (1989).
White, J. et al. Cell 56, 27–35 (1989).
Kappler, J. W., Roehm, N. & Marrack, P. Cell 49, 273–280 (1987).
Marrack, P. & Kappler, J. Nature 332, 840–843 (1988).
Kappler, J. W., Staerz, U., White, J. Nature 332, 35–40 (1988).
MacDonald, H. R. et al. Nature 332, 40–45 (1988).
Okada, C. Y., Holzmann, B., Guidos, C., Palmer, E. & Weissman, I. L. J. Immun. 144, 3473–3477 (1990).
Happ, M. P., Woodland, D. C. & Palmer, E. Proc. natn. Acad. Sci. U.S.A. 86, 6293–6296 (1989).
Abe, R., Foo-Phllips, M. & Hodes, R. J. J. exp. Med. 170, 1059–1073 (1989).
Pullen, A. M., Marrack, P. & Kappler, J. W. Nature 335, 796–801 (1988).
Tomonari, K. & Fairchild, S. Immunogenetics (in the press).
Woodland, D., Happ, M. P., Bill, J. & Palmer, E. Science 247, 964–967 (1990).
Tomonari, K. & Lovering, E. Immunogenetics 28, 445–451 (1988).
Bill, J., Kanagawa, O., Woodland, D. L. & Palmer, E. J. exp. Med. 169, 1405–1419 (1989).
Gibson, D. M., Maclean, S. J. & Cherry, M. Immunogenetics 18, 111–116 (1983).
Davidsson, M. T. & Roderick, T. H. in Genetic Variants and Strains of the Laboratory Mouse 2nd edn (eds Lyon, M. F. & Searle, A. G.) 416–427 (Oxford University Press, Oxford, 1989).
Love, J. M., Knight, A. M., McAleer, M. A. & Todd, J. A. Nucleic Acids Res. 18, 4123–4130 (1990).
Peters, G. J. Virol. 59, 535–544 (1986).
Tomonari, K. Immunol. Rev. 116, 139–157 (1990).
Vacchio, M. S., Ryan, J. J. & Hodes, R. J. J. exp. Med. 172, 807–813 (1990).
Tomonari, K. Immunogenetics 32, 60–62 (1990).
Marrack, P. & Kappler, J. Science 248, 705–711 (1990).
Fraser, J. D. Nature 339, 221–224 (1989).
Mollick, J. A., Coote, R. G. & Rich, R. R. Science 244, 817–821 (1989).
Janeway, C. A. Jr Immunol. Rev. 107, 61–88 (1989).
Henrard, D. & Ross, R. R. J. Virol. 62, 3046–3049 (1988).
King, L. B., Lund, F. E., White, D. A., Sharma, S. & Corley, R. B. J. Immun. 144, 3218–3227 (1989).
Heber-Katz, E. & Acha-Orbea, H. Immun. Today 10, 164–169 (1989).
Maniatis, T., Fritsch, E. F. & Sambrook, J. in Molecular Cloning: A Laboratory Manual (Cold Spring Harbor Laboratory, New York, 1982).
Gebhard, W. & Zachau, H. G. J. molec. Biol. 170, 567–573 (1983).
Knight, A. M. & Dyson, P. J. Molec. cell. Probes 4, 497–504 (1990).
Yang, J-N., Boyd, R. T., Gottlieb, P. D. & Dudley, J. P. Immunogenetics 25, 222–227 (1987).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Dyson, P., Knight, A., Fairchild, S. et al. Genes encoding ligands for deletion of Vβ11 T cells cosegregate with mammary tumour virus genomes. Nature 349, 531–532 (1991). https://doi.org/10.1038/349531a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/349531a0
This article is cited by
-
Tolerance: an overview and perspectives
Nature Reviews Nephrology (2010)
-
Rapamycin and T cell costimulatory blockade as post-transplant treatment promote fully MHC-mismatched allogeneic bone marrow engraftment under irradiation-free conditioning therapy
Bone Marrow Transplantation (2002)
-
Allogeneic bone marrow transplantation with co-stimulatory blockade induces macrochimerism and tolerance without cytoreductive host treatment
Nature Medicine (2000)
-
Mouse mammary tumor virus and its interaction with the immune system
Immunologic Research (1998)
-
Induction of high levels of allogeneic hematopoietic reconstitution and donor-specific tolerance without myelosuppressive conditioning
Nature Medicine (1997)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
